The novel inosine analogue INO-2002 protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type 1 diabetes

Jon Mabley, Pal Pacher, K.G.K. Murthy, W. Williams, G.J. Southan, A.L. Salzman, C. Szabo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)581-589
Number of pages9
JournalJournal of Endocrinology
Issue number3
Publication statusPublished - Sept 2008

Cite this